1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D9B4B5A205B329D185257D2B006D52A2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-science-liaison-management-service-scope-relationship-management-and-resource-management?opendocument
18
19opendocument
2044.222.134.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Field Medical Excellence

Medical Science Liaison Management: Service Scope, Relationship Management, and Resource Management

ID: 5319


Features:

11 Info Graphics

17 Data Graphics

150+ Metrics


Pages/Slides: 35


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Medical Science Liaison Management: Service Scope, Relationship Management, and Resource Management"


STUDY OVERVIEW

With the steady growth of the Medical Science Liaison (MSL) role in the healthcare industry, Medical Affairs leaders need to continually re-assess their MSL management practices to be successful in this competitive environment. This research, which presents 2014 data versus 2011, examines the growing roles and responsibilities of Medical Science Liaisons within leading healthcare organizations. The study captures critical insights across MSL operational, performance, and management fronts, including factors affecting the headcount, span of control, and deployment of MSLs.
Medical Affairs leaders can use this study as a benchmark for future strategic and resource planning and best-practice implementation for the medical science liaison function.

KEY TOPICS
  • Specialist Role and Service Scope
  • KOL Relationship Management
  • Resource Management/ Shifting and Forecasting

KEY METRICS
  • Level of the person with oversight responsibility for MSLs
  • Involvement level of MSLs in supporting the following product development activities
  • Timing for MSL involvement in supporting clinical trials
  • Effectiveness of factors affecting how MSLs are deployed
  • Stakeholder needs that drive alignment
  • Breakdown of MSL interaction types at regional and national thought leader levels
  • Level of face-to-face visits needed to maintain old and develop new relationships with regional thought leaders
  • Level of face-to-face visits needed to maintain old and develop new relationships with national thought leaders
  • Ratio of managers to MSLs
  • Effectiveness of factors used to determine field size of MSLs
  • Key factors for increasing the number of MSLs
  • Key factors for decreasing the number of MSLs
METHODOLOGY

Best Practices, LLC engaged 19 leaders at 15 top pharmaceutical companies through a benchmarking survey instrument.  All participants share leadership and oversight of  Medical Science Liaison (MSL) groups at their healthcare organizations. 

Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Medical Device; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; AstraZeneca Pharmaceuticals; Biogen; BARD; Baxter International; Bayer Healthcare; Covidien; Genentech; Gilead Sciences; Kadmon Pharmaceuticals; Medtronic; Sanofi; Shire; ViiV Healthcare; Jazz Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.